What Vitamins Should Not Be Taken With Anastrozole?

No vitamin carries a formal, absolute contraindication with anastrozole in standard prescribing information, but that does not mean every supplement is safe to take alongside it. Several categories of vitamins and plant-derived compounds can theoretically work against anastrozole’s mechanism, alter how the body metabolizes the drug, or complicate the side effects it already causes. The nuance matters because anastrozole is typically prescribed for years, and what you take daily over that time frame can quietly shift the drug’s effectiveness or your risk profile.

A Quick Look at How Anastrozole Works

Anastrozole belongs to a class of drugs called aromatase inhibitors. In postmenopausal women, estrogen is no longer produced primarily by the ovaries. Instead, an enzyme called aromatase converts other hormones into estrogen in fat tissue, muscle, and other peripheral sites. Anastrozole reversibly blocks that enzyme, driving estrogen levels down to near-undetectable ranges.¹ That suppression is the entire therapeutic point for hormone-receptor-positive breast cancer: starve the tumor of the estrogen it needs to grow. Anything that raises estrogen, interferes with aromatase inhibition, or changes how quickly the drug is cleared from the body has the potential to undermine treatment.

Phytoestrogen Supplements and Soy Isoflavones

Phytoestrogens are plant compounds that can weakly bind to estrogen receptors. They show up in concentrated form in soy isoflavone supplements, red clover extract capsules, and some “menopause support” blends. The concern is intuitive: if anastrozole’s job is to crush estrogen signaling, why would you take a supplement that mimics estrogen, even weakly?

The real-world picture is less straightforward than the theory. One cohort study specifically looked at soy consumption among postmenopausal women taking anastrozole and found that those consuming higher amounts of isoflavones actually had a lower risk of recurrence compared with women who consumed less.² That finding surprises a lot of people, and it does not settle the question. Dietary soy and concentrated isoflavone capsules are not the same thing. A serving of tofu delivers a modest dose of isoflavones alongside fiber, protein, and other compounds. A high-potency supplement can deliver far more, and the safety of those concentrated doses during aromatase inhibitor therapy has not been well tested in randomized trials.

Most oncologists take a middle-ground position: moderate dietary soy is generally fine, but high-dose isoflavone or red clover supplements should be avoided or at least discussed before starting. The worry is not about a bowl of edamame. It is about the 80-milligram isoflavone capsules marketed for hot flashes, which deliver a pharmacological dose of a compound that acts on estrogen pathways.

High-Dose Vitamin C

Standard multivitamin doses of vitamin C are not known to interfere with anastrozole. The concern arises at much higher concentrations, the kind used in intravenous vitamin C protocols sometimes promoted as complementary cancer treatments. In laboratory studies, very high concentrations of vitamin C reduced breast cancer cell survival on their own and, when combined with certain endocrine therapies like tamoxifen or fulvestrant, reduced it further.³

At first glance, that sounds like a good thing. But cell-culture experiments do not translate neatly to what happens inside a person. Vitamin C at high doses acts as a pro-oxidant rather than an antioxidant, and that shift can cut both ways: it might damage cancer cells, or it might interfere with the oxidative stress mechanisms some cancer therapies rely on. The same unpredictability applies to high-dose antioxidant supplements in general, including vitamin E and beta-carotene. Some older evidence suggests that flooding the body with antioxidants during cancer treatment could protect tumor cells from the damage treatment is trying to inflict. For anastrozole specifically, the mechanism of action is hormonal rather than oxidative, so the risk is more theoretical than proven. Still, most cancer centers advise against megadose vitamin C infusions or high-dose antioxidant supplements during active treatment unless they are part of a supervised clinical trial.

Flavonoid and Citrus Extract Supplements

This is where things get genuinely confusing. Flavonoids are a broad class of plant compounds found in citrus fruits, berries, tea, and wine. Certain flavonoids, including quercetin, naringenin, and naringin, have been shown in laboratory studies to inhibit aromatase themselves. Some of these compounds matched or even exceeded the aromatase-blocking potency of ketoconazole, a standard comparison drug, in cell-based assays.⁴ Flavonoids more broadly have been studied as potential aromatase inhibitors with anti-proliferative effects on breast cancer cells.⁵

You might think that taking a supplement with aromatase-inhibiting properties alongside an aromatase inhibitor would be helpful, like doubling down. But pharmacology does not always work that way. Two compounds that both target the same enzyme can compete for its binding site rather than cooperate. Anastrozole is a reversible inhibitor: it binds to aromatase, blocks it, and then eventually lets go. If a flavonoid from a supplement is occupying the same binding pocket at a lower potency, it could effectively displace the pharmaceutical drug and result in weaker, not stronger, inhibition. Whether this actually happens at the doses found in supplements is not established in human studies, but the theoretical risk is real enough that concentrated quercetin, naringenin, or citrus bioflavonoid extracts deserve a conversation with your oncologist before you add them to your routine.

Eating an orange is not the same as taking a 500-milligram quercetin capsule. Whole-food amounts of these compounds are low enough that they are unlikely to compete meaningfully with a pharmaceutical aromatase inhibitor. The concern is specific to concentrated supplement forms.

Herbal Supplements and Drug Metabolism

Anastrozole is metabolized in the liver by a family of enzymes called cytochrome P450, particularly CYP3A4. A number of herbal products commonly used by cancer patients can either speed up or slow down these enzymes, changing how much active drug remains in your bloodstream. St. John’s wort is the best-known offender: it powerfully induces CYP3A4, which means it can cause your body to break down anastrozole faster than intended, lowering blood levels and potentially reducing the drug’s effectiveness. Herbal products more broadly have been shown to affect the metabolism and transport of anticancer agents through these enzyme pathways.⁶

Other commonly flagged herbs include ginkgo biloba, echinacea, and goldenseal, all of which interact with CYP enzymes to varying degrees. The practical problem is that “herbal supplement” labels rarely tell you which CYP pathways the product affects, and the doses of active compounds can vary wildly between brands. Black cohosh, often taken for menopausal symptoms that anastrozole itself worsens, has been a particular source of debate. Some studies suggest it does not have meaningful estrogenic activity, while others raise concerns about liver enzyme effects. The safest course is to bring every supplement bottle to your oncology appointment and let your team check for interactions. This applies to “natural” and “plant-based” products just as much as to synthetic vitamins.

Vitamin D and Calcium Are Usually Encouraged, Not Avoided

One of the most common misconceptions is that you should avoid all supplements while on anastrozole. Vitamin D and calcium are the major exceptions, and they are not just permitted but actively recommended by most oncology guidelines. Anastrozole accelerates bone mineral density loss because estrogen plays a protective role in bone maintenance. Slam estrogen levels to the floor, and bone thinning follows. Clinical guidelines in most countries call for calcium and vitamin D supplementation alongside bone density monitoring during aromatase inhibitor therapy.⁷ Weight-bearing exercise and smoking cessation are also part of the standard bone-protection strategy.⁸

Here is the frustrating part: the doses typically tested in clinical trials, ranging from about 500 to 1,500 milligrams of calcium and 200 to 1,000 IU of vitamin D per day, were not enough to actually prevent bone density loss in women undergoing breast cancer therapy.⁹ They slowed the decline but did not stop it. Many oncologists now prescribe higher vitamin D doses, often 2,000 IU or more daily, especially if blood tests show low 25-hydroxyvitamin D levels. Some patients need bisphosphonate drugs or other bone-targeted therapies on top of supplementation. The key takeaway: do not lump vitamin D and calcium in with the supplements you should worry about. They belong in your routine, and the real question is whether you are getting enough of them, not whether you should avoid them.

Omega-3 Fatty Acids and Joint Pain

Joint and muscle pain are among the most common reasons women stop taking anastrozole. Researchers have explored whether omega-3 fatty acid supplements could ease this side effect, and the results are a mixed bag. A randomized trial in the SWOG cooperative group found that omega-3 supplements significantly reduced pain scores in obese patients taking aromatase inhibitors compared with placebo, but there was no meaningful benefit in non-obese patients.¹⁰ A separate pilot trial found no significant difference in pain between the omega-3 group and the placebo group at any time point, with joint pain increasing at a similar rate in both arms over the first 24 weeks of aromatase inhibitor use.¹¹

Omega-3 supplements are not known to interfere with anastrozole’s aromatase-blocking mechanism, so they fall into the “probably fine but benefits uncertain” category. If you are obese and struggling with joint pain on an aromatase inhibitor, the evidence gives some reason to try fish oil. If you are not obese, the data so far do not show a clear advantage. Either way, omega-3 supplements are one of the few over-the-counter options that have actually been tested in this specific patient population, which puts them ahead of most supplements people reach for.

How Common Are Supplement Interactions in Cancer Patients

If you are taking supplements alongside anastrozole, you are far from alone, and that is part of the problem. A study examining medication interactions in breast and prostate cancer patients found that roughly four out of five used herbs or supplements. Among those users, more than half had at least one potential interaction with their other medications, and the risk of a major interaction was significantly higher in supplement users than non-users.¹² Supplement use actually increased after chemotherapy ended, from about half of patients during treatment to about two-thirds afterward, and the prevalence of supplement-related interactions rose along with it.

The timing is relevant for anastrozole users. Most people start anastrozole after completing surgery and sometimes chemotherapy, which means they begin the drug right in the window when supplement use tends to climb. Patients feel they are “done with the hard part” and begin adding supplements for energy, bone health, immune support, or lingering side effects. Each of those additions can carry its own interaction risk, and the cumulative effect of multiple supplements is harder to predict than any single one.

The most practical step you can take is to treat supplements like medication: bring the actual bottles to every oncology visit, including anything labeled “natural,” “herbal,” or “food-based.” Oncology pharmacists are specifically trained to screen for these interactions and can often suggest safer alternatives. A vitamin D supplement and a daily calcium tablet are almost certainly fine and probably necessary. A shelf full of concentrated botanical extracts, high-dose antioxidants, and phytoestrogen capsules is a different story, and each one deserves individual scrutiny before you take it alongside a drug designed to run for five to ten years.

Supplements That Probably Do Not Cause Problems

Not every supplement needs to be a source of anxiety. Standard-dose B-complex vitamins, iron (if prescribed for anemia), magnesium, and zinc have no established interaction with anastrozole’s mechanism or metabolism. A basic daily multivitamin at recommended dietary allowance levels is generally considered safe. The trouble starts with megadoses, concentrated plant extracts, and products marketed for hormonal balance or immune boosting, because those categories are where estrogenic activity, enzyme interference, and antioxidant overload tend to lurk.

If you are considering a new supplement, a useful screening question is: does this product claim to affect hormones, boost estrogen, support menopause symptoms, or provide “immune modulation”? If the answer is yes, the product is more likely to interact with an aromatase inhibitor than a straightforward mineral or B vitamin. Products that explicitly advertise hormonal effects are, by definition, acting on the same biological pathways anastrozole is trying to suppress. That does not mean they are all dangerous, but it does mean they all warrant a conversation with your treatment team before you start taking them.